A Phase 1a/1b Study of CB4211 in Healthy Non-obese Subjects and Subjects With Nonalcoholic Fatty Liver Disease

NCT03998514 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Nonalcoholic Fatty Liver Disease

Interventions

DRUG: CB4211 Dose 1
DRUG: CB4211 Dose 2
DRUG: CB4211 Dose 3
DRUG: CB4211 Dose 4
DRUG: CB4211 Dose 5
DRUG: CB4211 Dose 6
DRUG: CB4211 Dose TBD
DRUG: Placebo

Sponsor

CohBar, Inc.